The Michael J. Fox Foundation
Annual Letter from the CEO and the Co-Founder
Todd Sherer, PhD,( right) with David Standaert, MD, PhD, at the annual PD Therapeutics Conference
Debi Brooks with Michael J. Fox at an MJFF salon sharing research progress
Dear Friend,
Understanding Parkinson’ s disease is the starting point of every effort to accelerate the cure. Years of work spent uncovering Parkinson’ s secrets— defining the highly variable patient experience, shedding light on genetic origins of disease, mapping molecular pathways— are now paying off in a tangibly quickening tempo of progress. Researchers are increasingly linking pathology to clinical symptoms( and vice versa) to inform therapeutic target and biomarker identification.
4